Skip to content
AwardedPOLGoods

Sukcesywne dostawy produktu leczniczego Eribulin dla Narodowego Instytutu Onkologii im. Marii Skłodowskiej-Curie - Państwowego Instytutu Badawczego Oddziału w Gliwicach

Published
Published 27 May 2026
Deadline
Closed 12 June 2026

Overview

The National Oncology Institute in Gliwice procured successive deliveries of the pharmaceutical product Eribulin. The contract was awarded to Baxter Polska Sp. z o.o. on 30 June 2026 for a total value of 526,799.99 PLN.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
Published
27 May 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 526,800
Award date
30 June 2026
Contract period
— → 19 June 2028
Winner
  • Baxter Polska Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 July 2026

  2. Contract Notice

    27 May 2026

Contracting authority

  • Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Oddział w Gliwicach

    Procuring entity

    Gliwice, POL

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Sukcesywne dostawy produktu leczniczego Eribulin dla Narodowego Instytutu Onkologii im. Marii Skłodowskiej-Curie - Państwowego Instytutu Badawczego Oddziału w Gliwicach — won by Baxter Polska Sp. z o.o. — Skim